Erythrocyte catechol-O-methyltransferase, platelet monoamine oxidase, and platelet phenol sulfotransferase activities in patients with prolactin-secreting pituitary adenomas.
Dopamine is metabolized by oxidative deamination catalyzed by monoamine oxidase, O-methylation catalyzed by catechol-O-methyltransferase, and sulfate conjugation catalyzed by phenol sulfotransferase. This study was performed to determine whether platelet monoamine oxidase, red blood cell catechol-O-methyltransferase and platelet phenol sulfotransferase enzymatic activities in patients with prolactinomas were quantitatively different from the same enzyme activities in blood samples from normal subjects. The mean enzyme activities in blood samples from 22 women with histologically proven prolactinomas were compared to the mean enzyme activities in blood samples from 32 normal women. The blood levels of these 3 enzymatic activities were not significantly different between the two groups (P greater than 0.4). If the regulation of these catecholamine-metabolizing enzyme activities in blood elements reflects the regulation of the enzymes in the hypothalamic-hypophyseal region, these results suggest that a defect in the regulation of dopamine-metabolizing enzymes is not associated with the pathogenesis of prolactinomas.
D000236:Adenoma / Q000201:enzymology*; D000328:Adult; D015239:Arylsulfotransferase; D001792:Blood Platelets / Q000201:enzymology; D002394:Catechol O-Methyltransferase / Q000097:blood; D004298:Dopamine / Q000378:metabolism*; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D008995:Monoamine Oxidase / Q000097:blood; D010911:Pituitary Neoplasms / Q000201:enzymology*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D013466:Sulfurtransferases / Q000097:blood
D011388:Prolactin; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase; D013466:Sulfurtransferases; D015239:Arylsulfotransferase; D004298:Dopamine